Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMC 3670653)

Published in Am J Public Health on March 14, 2013

Authors

Robert P Schwartz1, Jan Gryczynski, Kevin E O'Grady, Joshua M Sharfstein, Gregory Warren, Yngvild Olsen, Shannon G Mitchell, Jerome H Jaffe

Author Affiliations

1: Friends Research Institute, Baltimore, MD 21201, USA. Rschwartz@friendsresearch.org

Articles citing this

National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment. Am J Public Health (2015) 1.39

Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature. Am J Public Health (2015) 0.99

High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy (2014) 0.91

The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug Alcohol Depend (2015) 0.90

Efforts to reduce overdose deaths. Am J Public Health (2013) 0.88

A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world. J Addict Med (2014) 0.86

Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies. Yale J Biol Med (2015) 0.86

Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status. J Drug Issues (2014) 0.82

Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists. J Addict Med (2016) 0.80

Buprenorphine Prescribing: To Expand or Not to Expand. J Psychiatr Pract (2016) 0.79

Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research. J Addict Dis (2015) 0.79

Italy's electronic health record system for opioid agonist treatment. J Subst Abuse Treat (2013) 0.78

Methadone treatment providers' views of drug court policy and practice: a case study of New York State. Harm Reduct J (2013) 0.78

Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City. Drug Alcohol Depend (2016) 0.77

Managing Opioid Use Disorder During and After Acute Hospitalization: A Case-Based Review Clarifying Methadone Regulation for Acute Care Settings. J Addict Behav Ther Rehabil (2015) 0.76

Patient-centered methadone treatment: a randomized clinical trial. Addiction (2016) 0.75

Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist. Postgrad Med J (2016) 0.75

Primary care physicians' perspectives on the prescription opioid epidemic. Drug Alcohol Depend (2016) 0.75

Characteristics of Homeless Adults Who Died of Drug Overdose: A Retrospective Record Review. J Health Care Poor Underserved (2016) 0.75

Opioid Overdose Experience, Risk Behaviors, and Knowledge in Drug Users from a Rural versus an Urban Setting. J Subst Abuse Treat (2016) 0.75

Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention. J Subst Abuse Treat (2015) 0.75

Schwartz et al. respond. Am J Public Health (2013) 0.75

Substance use disorders and avoidable mortality after prison. Lancet Psychiatry (2015) 0.75

Doctor Shopping Behavior and the Diversion of Prescription Opioids. Subst Abuse (2017) 0.75

The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use. Drug Alcohol Depend (2017) 0.75

Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study. Ann Fam Med (2017) 0.75

Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. Int J Drug Policy (2017) 0.75

Articles cited by this

Release from prison--a high risk of death for former inmates. N Engl J Med (2007) 12.46

Effects of a sustained heroin shortage in three Australian States. Addiction (2005) 6.62

Role of maintenance treatment in opioid dependence. Lancet (1999) 6.02

Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. Addiction (2003) 4.36

Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther (1994) 2.90

Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ (2003) 2.80

Heroin overdose: research and evidence-based intervention. J Urban Health (2003) 2.66

Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction (2008) 2.53

Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy (2008) 2.10

Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav (2005) 2.09

Heroin-related deaths in New South Wales, Australia, 1992-1996. Drug Alcohol Depend (2000) 2.07

Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend (2007) 2.00

French field experience with buprenorphine. Am J Addict (2004) 1.96

Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction (2005) 1.96

Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction (2007) 1.81

Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend (1999) 1.69

The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health (2001) 1.66

Methadone maintenance and addicts' risk of fatal heroin overdose. Subst Use Misuse (1996) 1.64

From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States. Drug Alcohol Depend (2003) 1.56

The effect of neighborhood deprivation and residential relocation on long-term injection cessation among injection drug users (IDUs) in Baltimore, Maryland. Addiction (2011) 1.46

Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br J Anaesth (2005) 1.44

Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence. J Addict Dis (2009) 1.42

Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants. Drug Alcohol Depend (2005) 1.33

Heroin-related deaths: new epidemiologic insights. Science (1984) 1.28

Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. Am J Addict (2009) 1.24

"The life they save may be mine": diffusion of overdose prevention information from a city sponsored programme. Int J Drug Policy (2008) 1.23

Deaths by unintentional illicit drug overdose in Italy, 1984-2000. Drug Alcohol Depend (2002) 1.20

Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City. Addict Behav (2011) 1.20

Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers. J Subst Abuse Treat (2010) 1.17

The role of methadone in drug-related deaths in the west of Scotland. Addiction (2003) 1.14

Trajectories of injection drug use over 20 years (1988-2008) in Baltimore, Maryland. Am J Epidemiol (2011) 1.09

Disposition of heroin and its metabolites in heroin-related deaths. J Anal Toxicol (1994) 1.07

Deaths involving buprenorphine: a compendium of French cases. Forensic Sci Int (2001) 1.03

London audit of drug-related overdose deaths: characteristics and typology, and implications for prevention and monitoring. Addiction (2007) 1.01

Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning. Eur J Clin Pharmacol (2011) 0.97

Acute drug-related mortality of people recently released from prisons. Public Health (2010) 0.95

Quality of heroin and heroin-related deaths from 1987 to 1995 in Vienna, Austria. Addiction (2000) 0.83

A reduction in blood morphine concentrations amongst heroin overdose fatalities associated with a sustained reduction in street heroin purity. Forensic Sci Int (2010) 0.79

Articles by these authors

Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med (2010) 3.84

Energy drink consumption and increased risk for alcohol dependence. Alcohol Clin Exp Res (2010) 3.14

A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry (2006) 2.98

Drug exposure opportunities and use patterns among college students: results of a longitudinal prospective cohort study. Subst Abus (2008) 2.95

Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings. Addiction (2012) 2.47

A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release. Addiction (2008) 2.45

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend (2005) 2.26

Increased alcohol consumption, nonmedical prescription drug use, and illicit drug use are associated with energy drink consumption among college students. J Addict Med (2010) 2.19

Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict (2008) 2.17

The occurrence of cannabis use disorders and other cannabis-related problems among first-year college students. Addict Behav (2007) 2.11

A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat (2009) 2.03

Molecular shape and medicinal chemistry: a perspective. J Med Chem (2010) 1.91

Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain (2013) 1.89

Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat (2008) 1.77

The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment. Drug Alcohol Depend (2007) 1.75

Computerized versus in-person brief intervention for drug misuse: a randomized clinical trial. Addiction (2014) 1.75

Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy (2008) 1.73

Why don't out-of-treatment individuals enter methadone treatment programmes? Int J Drug Policy (2008) 1.73

Maryland's all-payer approach to delivery-system reform. N Engl J Med (2014) 1.67

Perceived harmfulness predicts nonmedical use of prescription drugs among college students: interactions with sensation-seeking. Prev Sci (2008) 1.65

Regulatory action on rosiglitazone by the U.S. Food and Drug Administration. N Engl J Med (2010) 1.59

Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users. Addiction (2003) 1.58

A Study of Methadone Maintenance For Male Prisoners: 3-Month Postrelease Outcomes. Crim Justice Behav (2008) 1.54

Prevalence and predictors of persistent suicide ideation, plans, and attempts during college. J Affect Disord (2010) 1.54

A randomized controlled trial of interim methadone maintenance: 10-Month follow-up. Drug Alcohol Depend (2006) 1.51

Attitudes toward buprenorphine and methadone among opioid-dependent individuals. Am J Addict (2008) 1.51

Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med (2012) 1.43

Premature discharge from methadone treatment: patient perspectives. J Psychoactive Drugs (2009) 1.42

Suicide ideation among college students: a multivariate analysis. Arch Suicide Res (2009) 1.35

Nonmedical use of prescription stimulants during college: four-year trends in exposure opportunity, use, motives, and sources. J Am Coll Health (2012) 1.32

Sharing and selling of prescription medications in a college student sample. J Clin Psychiatry (2010) 1.31

In-treatment vs. out-of-treatment opioid dependent adults: drug use and criminal history. Am J Drug Alcohol Abuse (2008) 1.31

Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial. Ann Intern Med (2010) 1.27

Maintaining Superior Follow-Up Rates in a Longitudinal Study: Experiences from the College Life Study. Int J Mult Res Approaches (2012) 1.27

Predictors of methadone treatment retention from a multi-site study: a survival analysis. Drug Alcohol Depend (2011) 1.26

Dispelling the myth of "smart drugs": cannabis and alcohol use problems predict nonmedical use of prescription stimulants for studying. Addict Behav (2012) 1.25

College students rarely seek help despite serious substance use problems. J Subst Abuse Treat (2009) 1.24

Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. Am J Addict (2009) 1.24

The FDA as a public health agency. N Engl J Med (2009) 1.21

Marijuana exposure opportunity and initiation during college: parent and peer influences. Prev Sci (2012) 1.20

Dear health care lobbyists . . . Milbank Q (2015) 1.19

Interim methadone treatment compared to standard methadone treatment: 4-month findings. J Subst Abuse Treat (2011) 1.19

Drug use patterns and continuous enrollment in college: results from a longitudinal study. J Stud Alcohol Drugs (2013) 1.17

Evidence for significant polydrug use among ecstasy-using college students. J Am Coll Health (2006) 1.17

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes. Subst Abuse (2013) 1.16

High school drinking mediates the relationship between parental monitoring and college drinking: a longitudinal analysis. Subst Abuse Treat Prev Policy (2008) 1.14

Factors that predict adolescent motivation for substance abuse treatment. J Subst Abuse Treat (2003) 1.13

Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment. Am J Addict (2011) 1.13

Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned. Addiction (2012) 1.13

An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students. Subst Use Misuse (2005) 1.12

SBIRT for adolescent drug and alcohol use: current status and future directions. J Subst Abuse Treat (2013) 1.12

Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data. Am J Addict (2013) 1.10

Interim methadone treatment: impact on arrests. Drug Alcohol Depend (2009) 1.09

Gender Differences Among In- and Out-of-Treatment Opioid-Addicted Individuals. Am J Drug Alcohol Abuse (2009) 1.08

Persistent nonmedical use of prescription stimulants among college students: possible association with ADHD symptoms. J Atten Disord (2010) 1.07

The Community Assessment Inventory--client views of supports to drug abuse treatment. J Subst Abuse Treat (2004) 1.07

The role of patient satisfaction in methadone treatment. Am J Drug Alcohol Abuse (2010) 1.07

College students' use of cocaine: results from a longitudinal study. Addict Behav (2010) 1.06

A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans. Drug Alcohol Depend (2012) 1.05

Marijuana use trajectories during the post-college transition: health outcomes in young adulthood. Drug Alcohol Depend (2012) 1.03

Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime. Subst Abus (2012) 1.03

Trends in alcohol-related traffic risk behaviors among college students. Alcohol Clin Exp Res (2010) 1.03

Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care. Drug Alcohol Depend (2011) 1.02

Transparency at the Food and Drug Administration. N Engl J Med (2010) 1.01

Incarcerated drug-abusing mothers: their characteristics and vulnerability. Am J Drug Alcohol Abuse (2005) 1.01

Social context of drinking and alcohol problems among college students. Am J Health Behav (2007) 1.01

Treating the partners of opioid-dependent pregnant patients: feasibility and efficacy. Am J Drug Alcohol Abuse (2011) 1.00

Opioid use disorder in the United States: insurance status and treatment access. Drug Alcohol Depend (2008) 1.00

Patterns in admission delays to outpatient methadone treatment in the United States. J Subst Abuse Treat (2011) 0.99

Lessons learned from a randomized trial of fixed and escalating contingency management schedules in opioid-dependent pregnant women. Am J Drug Alcohol Abuse (2012) 0.97

Evaluation of a group-based substance abuse treatment program for adolescents. J Subst Abuse Treat (2004) 0.96

Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale. Subst Use Misuse (2010) 0.96

The association between early conduct problems and early marijuana use in college students. J Child Adolesc Subst Abuse (2011) 0.96

Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts. Drug Alcohol Depend (2010) 0.96

Chronic pain, addiction, and Zohydro. N Engl J Med (2014) 0.96

Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes. Drug Alcohol Depend (2012) 0.95

Nonmedical prescription analgesic use and concurrent alcohol consumption among college students. Am J Drug Alcohol Abuse (2009) 0.95

Electronic cigarettes in adults in outpatient substance use treatment: Awareness, perceptions, use, and reasons for use. Am J Addict (2015) 0.95

Scaling-up interim methadone maintenance: treatment for 1,000 heroin-addicted individuals. J Subst Abuse Treat (2009) 0.95

Neonatal abstinence scores in opioid-exposed and nonexposed neonates: a blinded comparison. J Opioid Manag (2011) 0.94

Twice stigmatized: provider's perspectives on drug-using women in the Republic of Georgia. J Psychoactive Drugs (2013) 0.94

Cigarette smoking among college students: longitudinal trajectories and health outcomes. Nicotine Tob Res (2012) 0.93

The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. Am J Drug Alcohol Abuse (2009) 0.93

Drug use patterns in young adulthood and post-college employment. Drug Alcohol Depend (2012) 0.93

EMS runs for suspected opioid overdose: implications for surveillance and prevention. Prehosp Emerg Care (2013) 0.92

Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome. Addiction (2007) 0.92

Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system. Am J Addict (2013) 0.92